What is Synopsys Inc's earnings per share (EPS)?

Synopsys Inc (SNPS) reported diluted earnings per share of $8.04 for fiscal year 2025. This represents a -44.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Synopsys Inc (SNPS) Financials

SNPS

Trailing 12 months to July 31, 2026

Revenue $9.4B +46.3% YoY

Net Income $1.1B -46.1% YoY

EPS (Diluted) $5.72 -55.1% YoY

Free Cash Flow $2.7B +113.7% YoY

Market Cap $75.5B as of Sep 5, 2026

Price / Sales 8.0x on $9.4B revenue, trailing 12 months to July 31, 2026

Price / Earnings 70.1x on $1.1B net income, trailing 12 months to July 31, 2026

Price / Book 2.4x on $31.2B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 31, 2026 Reported Aug 26, 2026 Currency USD FYE October

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SNPS SEC filings page.

Synopsys Inc (SNPS) reported $9.4B in revenue over the twelve months to Jul 31, 2026, up 46.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNPS FY2025 2026-08-30

FY2025 paired revenue growth with margin compression as debt-supported balance-sheet expansion reshaped earnings economics.

Goodwill rose to $26.9B from $3.4B, signaling a fundamentally different capital structure rather than ordinary operating growth. Debt climbed to $13.5B and interest expense to $446.7M while operating margin compressed; financing costs and heavier operating costs absorbed more of the revenue increase.

Revenue growth accelerated in FY2025, but operating margin fell from 22.1% to 13.0% as SG&A and R&D rose faster than sales. That indicates reversed operating leverage: additional revenue produced less operating profit.

Operating cash flow remained above net income in FY2025, and free cash flow stayed positive after capital spending; this makes cash generation less dependent on reported earnings than the sharp FY2024 profit peak would suggest. The current ratio also fell from 2.4x to 1.6x, showing that the balance-sheet expansion reduced the earlier short-term liquidity cushion.

Financial Health Signals

Financial Health Score 57/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Synopsys Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Synopsys Inc has an operating margin of 13.0%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 63/100, indicating healthy but not exceptional operating efficiency. This is down from 22.1% the prior year.

Growth

Synopsys Inc's revenue surged 15.1% year-over-year to $7.1B, reflecting rapid business expansion. This strong growth earns a score of 76/100.

Leverage

Synopsys Inc has elevated debt relative to equity (D/E of 0.48), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 8/100, reflecting increased financial risk.

Liquidity

Synopsys Inc's current ratio of 1.62 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Synopsys Inc converts 19.1% of revenue into free cash flow ($1.3B). This strong cash generation earns a score of 88/100.

Returns

Synopsys Inc's ROE of 4.7% shows moderate profitability relative to equity, earning a score of 60/100. This is down from 25.2% the prior year.

Altman Z-Score Grey Zone

2.84

Synopsys Inc scores 2.84, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($75.5B) relative to total liabilities ($19.9B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

Synopsys Inc passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.14x

For every $1 of reported earnings, Synopsys Inc generates $1.14 in operating cash flow ($1.5B OCF vs $1.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.05x

Synopsys Inc earns $2.05 in operating income for every $1 of interest expense ($914.9M vs $446.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5B

YoY+42.4%

QoQ+8.8%

5Y CAGR+18.6%

10Y CAGR+14.9%

Synopsys Inc generated $2.5B in revenue in Q3 2026. This represents an increase of 42.4% from the same quarter a year earlier. Against the prior quarter it is up 8.8%.

EBITDA

$812.3M

YoY+190.4%

QoQ+40.8%

5Y CAGR+26.3%

Synopsys Inc's EBITDA was $812.3M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 190.4% from the same quarter a year earlier. Against the prior quarter it is up 40.8%.

Net Income

$545.8M

YoY+125.1%

QoQ+3090.9%

5Y CAGR+22.4%

10Y CAGR+23.8%

Synopsys Inc reported $545.8M in net income in Q3 2026. This represents an increase of 125.1% from the same quarter a year earlier. Against the prior quarter it is up 3090.9%.

EPS (Diluted)

$2.84

YoY+89.3%

QoQ+3055.6%

5Y CAGR+17.5%

10Y CAGR+21.1%

Synopsys Inc earned $2.84 per diluted share (EPS) in Q3 2026. This represents an increase of 89.3% from the same quarter a year earlier. Against the prior quarter it is up 3055.6%.

Cash & Balance Sheet

Free Cash Flow

$746.3M

YoY+18.0%

QoQ+29.8%

5Y CAGR+13.3%

10Y CAGR+12.4%

Synopsys Inc generated $746.3M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 18.0% from the same quarter a year earlier. Against the prior quarter it is up 29.8%.

Cash & Debt

$3.6B

YoY+42.7%

QoQ+49.5%

5Y CAGR+21.1%

10Y CAGR+14.3%

Synopsys Inc held $3.6B in cash against $9.0B in long-term debt as of Q3 2026.

Shares Outstanding

192M

YoY+3.2%

QoQ+0.1%

5Y CAGR+4.7%

10Y CAGR+2.4%

Synopsys Inc had 192M shares outstanding in Q3 2026. This represents an increase of 3.2% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

72.6%

YoY-5.6pp

QoQ+0.2pp

5Y CAGR-8.0pp

10Y CAGR-4.7pp

Synopsys Inc's gross margin was 72.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Operating Margin

14.4%

YoY+4.9pp

QoQ+9.1pp

5Y CAGR-4.7pp

Synopsys Inc's operating margin was 14.4% in Q3 2026, reflecting core business profitability. This is up 4.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.1 percentage points.

Net Margin

22.0%

YoY+8.1pp

QoQ+21.3pp

5Y CAGR+3.3pp

10Y CAGR+11.5pp

Synopsys Inc's net profit margin was 22.0% in Q3 2026, showing the share of revenue converted to profit. This is up 8.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 21.3 percentage points.

Return on Equity

1.8%

YoY+0.9pp

QoQ+1.7pp

5Y CAGR-2.1pp

10Y CAGR-0.3pp

Synopsys Inc's ROE was 1.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Capital Allocation

R&D Spending

$719.7M

YoY+15.1%

QoQ+2.8%

5Y CAGR+14.2%

Synopsys Inc invested $719.7M in research and development in Q3 2026. This represents an increase of 15.1% from the same quarter a year earlier. Against the prior quarter it is up 2.8%.

Share Buybacks

$37.5M

Synopsys Inc spent $37.5M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$66.6M

YoY+72.4%

QoQ+22.8%

5Y CAGR+23.8%

10Y CAGR+13.2%

Synopsys Inc invested $66.6M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 72.4% from the same quarter a year earlier. Against the prior quarter it is up 22.8%.

SNPS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNPS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.4B	$7.1B+15.1%	$6.1B+15.2%	$5.3B+4.7%	$5.1B+20.9%	$4.2B+14.1%	$3.7B+9.7%	$3.4B+7.7%	$3.1B+14.5%	$2.7B+12.5%	$2.4B+8.0%	$2.2B+9.0%	$2.1B+4.9%	$2.0B+11.7%	$1.8B+14.4%	$1.5B
Cost of Revenue	$2.6B	$1.6B+30.4%	$1.2B+20.8%	$1.0B+14.8%	$898.0M+4.2%	$861.8M+8.4%	$794.7M+5.5%	$752.9M+2.3%	$735.9M+12.5%	$654.2M+20.5%	$543.0M+4.6%	$518.9M+13.6%	$456.9M+0.7%	$453.6M+15.5%	$392.7M+15.3%	$340.4M
Gross Profit	$6.8B	$5.4B+11.2%	$4.9B+13.9%	$4.3B+15.3%	$3.7B+11.2%	$3.3B+15.6%	$2.9B+10.8%	$2.6B+9.3%	$2.4B+15.2%	$2.1B+10.2%	$1.9B+9.1%	$1.7B+7.7%	$1.6B+6.1%	$1.5B+10.7%	$1.4B+14.1%	$1.2B
R&D Expenses	$2.9B	$2.5B+19.1%	$2.1B+12.6%	$1.8B+16.4%	$1.6B+5.7%	$1.5B+17.7%	$1.3B+12.5%	$1.1B+4.8%	$1.1B+19.4%	$908.8M+6.1%	$856.7M+10.4%	$776.2M+8.0%	$718.8M+7.4%	$669.2M+15.1%	$581.6M+18.2%	$491.9M
SG&A Expenses	$717.6M	$769.6M+35.4%	$568.5M+50.9%	$376.7M+20.1%	$313.6M-2.9%	$323.0M+13.5%	$284.5M+24.1%	$229.2M-12.7%	$262.6M+33.4%	$196.8M+18.6%	$166.0M+0.5%	$165.1M+6.4%	$155.2M+7.9%	$143.8M-8.7%	$157.5M+39.6%	$112.8M
Operating Income	$802.4M	$914.9M-32.5%	$1.4B+6.5%	$1.3B+10.8%	$1.1B+56.3%	$734.8M+18.5%	$620.1M+19.2%	$520.2M+44.4%	$360.2M+3.6%	$347.6M+9.5%	$317.4M+19.1%	$266.5M+7.1%	$248.7M+0.9%	$246.5M+29.7%	$190.0M-10.7%	$212.8M
EBITDA	N/A	$1.6B-4.6%	$1.7B+8.6%	$1.5B+10.4%	$1.4B+46.7%	$938.5M+13.1%	$830.1M+15.0%	$721.9M+26.8%	$569.4M+6.0%	$537.0M+2.4%	$524.4M+9.6%	$478.3M+8.3%	$441.5M+1.8%	$433.9M+25.1%	$346.9M+1.6%	$341.4M
Interest Expense	$624.1M	$446.7M+1113.0%	$36.8M+3026.4%	$1.2M-30.6%	$1.7M-49.5%	$3.4M-34.5%	$5.1M-55.9%	$11.7M-25.3%	$15.6M+113.7%	$7.3M+93.7%	$3.8M+34.0%	$2.8M+48.5%	$1.9M+11.7%	$1.7M-14.8%	$2.0M+1871.3%	$101K
Income Tax	$223.0M	$56.0M-43.9%	$99.7M+10.6%	$90.2M-35.3%	$139.4M+183.6%	$49.2M+294.4%	-$25.3M-292.5%	$13.1M+119.0%	-$69.0M-128.0%	$246.5M+293.1%	$62.7M+12.7%	$55.7M+327.7%	$13.0M-53.3%	$27.9M+48.8%	$18.7M+932.2%	-$2.3M
Net Income	$1.1B	$1.3B-41.1%	$2.3B+84.0%	$1.2B+24.9%	$984.6M+30.0%	$757.5M+14.0%	$664.3M+24.8%	$532.4M+23.1%	$432.5M+216.7%	$136.6M-48.8%	$266.8M+18.1%	$225.9M-12.8%	$259.1M+4.6%	$247.8M+36.2%	$181.9M-17.8%	$221.4M
EPS (Basic)	N/A	$8.13-45.0%	$14.78+82.9%	$8.08+25.5%	$6.44+29.8%	$4.96+12.7%	$4.40+23.9%	$3.55+22.4%	$2.90+218.7%	$0.91-48.3%	$1.76+20.5%	$1.46-12.6%	$1.67+3.1%	$1.62+30.6%	$1.24-17.9%	$1.51
EPS (Diluted)	$5.72	$8.04-44.6%	$14.51+83.2%	$7.92+25.9%	$6.29+30.8%	$4.81+12.6%	$4.27+23.8%	$3.45+22.3%	$2.82+220.5%	$0.88-49.1%	$1.73+21.0%	$1.43-12.8%	$1.64+3.8%	$1.58+30.6%	$1.21-17.7%	$1.47
Diluted Shares (Avg)	N/A	166M+6.2%	156M+0.5%	155M-0.8%	156M-0.5%	157M+1.0%	156M+1.0%	154M+0.5%	153M-1.0%	155M+0.1%	155M-2.1%	158M+0.2%	158M+0.7%	157M+4.2%	150M-0.1%	150M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$2.5B+42.4%	$2.3B+41.9%	$2.4B+65.5%	$2.3B+37.8%	$1.7B+14.0%	$1.6B+10.3%	$1.5B-3.7%	$1.6B+22.1%
Cost of Revenue	$679.4M+78.5%	$629.9M+97.9%	$637.4M+136.1%	$654.7M+74.6%	$380.6M+30.9%	$318.3M+6.0%	$270.0M-3.3%	$375.0M+57.7%
Gross Profit	$1.8B+32.2%	$1.6B+28.0%	$1.8B+49.4%	$1.6B+26.9%	$1.4B+10.0%	$1.3B+11.4%	$1.2B-3.8%	$1.3B+14.5%
R&D Expenses	$719.7M+15.1%	$700.1M+26.4%	$715.0M+29.2%	$746.8M+34.6%	$625.3M+22.9%	$554.0M+12.3%	$553.2M+5.3%	$554.8M+26.2%
SG&A Expenses	$177.0M-36.9%	$172.4M+26.3%	$182.7M+9.4%	$185.5M+7.8%	$280.6M+86.5%	$136.5M+18.9%	$167.1M+27.3%	$172.0M+81.3%
Operating Income	$357.5M+116.3%	$120.4M-68.0%	$203.0M-19.4%	$121.4M-60.9%	$165.3M-54.1%	$376.4M+13.4%	$251.8M-28.6%	$310.8M-26.8%
EBITDA	$812.3M+190.4%	$576.9M+35.6%	$653.7M+118.1%	$570.5M+34.0%	$279.7M-32.8%	$425.3M+8.2%	$299.8M-27.9%	$425.7M-13.5%
Interest Expense	$133.2M-9.1%	$133.4M+41.4%	$162.7M+1360.8%	$194.8M+1066.5%	$146.5M+1147.7%	$94.3M+1234.9%	$11.1M+741.3%	$16.7M+6321.5%
Income Tax	$138.2M+360.9%	$2.4M-94.9%	$14.3M+327.8%	$68.1M+9.6%	-$53.0M-72.5%	$47.2M+3.8%	-$6.3M-127.5%	$62.1M-0.8%
Net Income	$545.8M+125.1%	$17.1M-95.0%	$65.0M-78.0%	$448.7M-59.7%	$242.5M-40.6%	$345.3M+18.2%	$295.7M-34.2%	$1.1B+219.1%
EPS (Basic)	$2.85+88.7%	$0.09-96.0%	$0.34-82.2%	$2.49-65.7%	$1.51-43.2%	$2.23+16.8%	$1.91-35.3%	$7.26+217.0%
EPS (Diluted)	$2.84+89.3%	$0.09-95.9%	$0.34-82.0%	$2.45-65.7%	$1.50-42.5%	$2.21+17.6%	$1.89-34.6%	$7.14+218.7%
Diluted Shares (Avg)	192M+18.9%	192M+23.1%	191M+22.1%	N/A	162M+3.6%	156M+0.2%	156M+0.6%	N/A

SNPS Balance Sheet

SNPS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$48.2B+268.9%	$13.1B+26.5%	$10.3B+9.7%	$9.4B+7.6%	$8.8B+9.0%	$8.0B+25.4%	$6.4B+4.2%	$6.1B+13.9%	$5.4B+3.0%	$5.2B+3.9%	$5.0B+5.7%	$4.8B+9.6%	$4.4B+5.1%	$4.1B+23.1%	$3.4B
Current Assets	$6.0B-7.1%	$6.5B+88.6%	$3.4B+13.9%	$3.0B+7.3%	$2.8B+10.2%	$2.5B+46.6%	$1.7B+12.6%	$1.5B-8.2%	$1.7B-2.0%	$1.7B+16.9%	$1.5B-2.4%	$1.5B+3.9%	$1.4B+26.9%	$1.1B-14.8%	$1.3B
Cash & Equivalents	$2.9B-25.9%	$3.9B+171.7%	$1.4B+1.2%	$1.4B-1.1%	$1.4B+16.0%	$1.2B+69.6%	$728.6M+0.8%	$723.1M-31.0%	$1.0B+7.3%	$976.6M+16.8%	$836.2M-15.2%	$985.8M-3.6%	$1.0B+46.0%	$700.4M-18.1%	$855.1M
Short-Term Investments	$72.9M-52.6%	$153.9M+1.5%	$151.6M+2.5%	$147.9M0.0%	$147.9M	$0	$0	$0	$0-100.0%	$140.7M+9.3%	$128.7M	$0	$0	$0-100.0%	$149.0M
Inventory	$365.2M+0.9%	$361.8M+11.1%	$325.6M+53.6%	$211.9M-7.5%	$229.0M+19.1%	$192.3M+35.9%	$141.5M+15.6%	$122.4M+97.8%	$61.9M	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.5B+61.1%	$934.5M+9.1%	$856.7M+7.6%	$796.1M+40.0%	$568.5M-27.2%	$780.7M+40.9%	$553.9M-0.1%	$554.2M+22.8%	$451.1M+2.8%	$438.9M+13.8%	$385.7M+18.0%	$326.7M+27.6%	$256.0M-12.5%	$292.7M+44.1%	$203.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$26.9B+679.9%	$3.4B+3.1%	$3.3B+7.2%	$3.1B-12.7%	$3.6B+6.3%	$3.4B+6.1%	$3.2B+0.9%	$3.1B+16.1%	$2.7B+7.5%	$2.5B+1.9%	$2.5B+9.6%	$2.3B+14.2%	$2.0B-0.1%	$2.0B+53.3%	$1.3B
Total Liabilities	$19.9B+391.3%	$4.1B-2.4%	$4.1B+7.5%	$3.9B+11.7%	$3.5B+10.8%	$3.1B+34.6%	$2.3B-13.0%	$2.7B+25.7%	$2.1B+3.5%	$2.0B+7.0%	$1.9B+11.2%	$1.7B+9.5%	$1.6B-2.1%	$1.6B+26.5%	$1.3B
Current Liabilities	$3.7B+40.5%	$2.7B-11.2%	$3.0B+7.6%	$2.8B+15.0%	$2.4B+12.8%	$2.1B+22.1%	$1.8B-16.6%	$2.1B+30.3%	$1.6B-5.9%	$1.7B+8.7%	$1.6B+13.8%	$1.4B+13.4%	$1.2B-2.4%	$1.3B+24.0%	$1.0B
Non-Current Liabilities	$16.2B+1055.2%	$1.4B+20.4%	$1.2B+7.3%	$1.1B+4.3%	$1.0B+6.3%	$977.8M+73.4%	$563.8M+0.9%	$558.5M+11.1%	$502.6M+52.2%	$330.3M-0.9%	$333.4M+0.2%	$332.6M-4.4%	$347.7M-0.9%	$351.0M+36.5%	$257.2M
Long-Term Debt	$13.5B+86191.9%	$15.6M-13.7%	$18.1M-13.2%	$20.8M-17.0%	$25.1M-75.1%	$100.8M-16.0%	$120.1M-4.3%	$125.5M-6.4%	$134.1M	$0	$0-100.0%	$45.0M-40.0%	$75.0M-28.6%	$105.0M	N/A
Total Equity	$28.3B+215.1%	$9.0B+46.3%	$6.1B+11.5%	$5.5B+4.2%	$5.3B+7.9%	$4.9B+20.2%	$4.1B+17.4%	$3.5B+6.2%	$3.3B+2.5%	$3.2B+2.0%	$3.1B+2.5%	$3.1B+9.6%	$2.8B+11.5%	$2.5B+19.1%	$2.1B
Retained Earnings	$10.3B+14.8%	$9.0B+33.3%	$6.7B+21.8%	$5.5B+21.6%	$4.5B+19.9%	$3.8B+20.0%	$3.2B+24.4%	$2.5B+18.6%	$2.1B+10.1%	$1.9B+12.9%	$1.7B+11.2%	$1.6B+17.1%	$1.3B+20.6%	$1.1B+14.7%	$957.5M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$47.7B-1.0%	$46.9B+97.4%	$47.2B+262.2%	$48.2B+268.9%	$48.2B+314.0%	$23.8B+115.7%	$13.0B+23.5%	$13.1B+26.5%
Current Assets	$6.6B+18.7%	$5.4B-67.8%	$5.4B-15.0%	$6.0B-7.1%	$5.6B+9.1%	$16.9B+262.7%	$6.3B+85.6%	$6.5B+88.6%
Cash & Equivalents	$3.6B+42.7%	$2.4B-82.9%	$2.1B-41.7%	$2.9B-25.9%	$2.5B+37.3%	$14.1B+839.4%	$3.7B+226.5%	$3.9B+171.7%
Short-Term Investments	$1.4M-97.9%	$72.0M-50.3%	$73.9M-52.5%	$72.9M-52.6%	$67.2M-56.5%	$144.8M-7.6%	$155.5M+0.6%	$153.9M+1.5%
Inventory	$479.1M+25.4%	$441.8M+11.8%	$393.2M-5.3%	$365.2M+0.9%	$382.1M-1.0%	$395.3M+4.6%	$415.2M+8.5%	$361.8M+11.1%
Accounts Receivable	$1.3B-5.3%	$1.3B+26.5%	$1.6B+83.8%	$1.5B+61.1%	$1.4B+72.9%	$1.0B+20.0%	$892.6M-16.1%	$934.5M+9.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$26.8B-0.4%	$26.9B+675.8%	$26.9B+682.9%	$26.9B+679.9%	$26.9B+682.3%	$3.5B+1.0%	$3.4B-16.9%	$3.4B+3.1%
Total Liabilities	$16.6B-19.6%	$16.4B+18.6%	$16.7B+346.7%	$19.9B+391.3%	$20.6B+428.2%	$13.8B+262.0%	$3.7B-3.0%	$4.1B-2.4%
Current Liabilities	$5.0B+44.3%	$3.8B+57.5%	$3.9B+67.2%	$3.7B+40.5%	$3.4B+35.9%	$2.4B-4.1%	$2.4B-10.8%	$2.7B-11.2%
Non-Current Liabilities	$11.6B-32.4%	$12.6B+10.4%	$12.7B+825.3%	$16.2B+1055.2%	$17.2B+1155.0%	$11.4B+769.8%	$1.4B+14.1%	$1.4B+20.4%
Long-Term Debt	$9.0B-37.0%	$10.0B-0.1%	$10.0B+70378.9%	$13.5B+86191.9%	$14.3B+91688.0%	$10.0B+59025.5%	$14.2M-16.1%	$15.6M-13.7%
Total Equity	$31.2B+12.8%	$30.5B+207.4%	$30.5B+228.3%	$28.3B+215.1%	$27.6B+258.2%	$9.9B+38.6%	$9.3B+39.5%	$9.0B+46.3%
Retained Earnings	$10.9B+10.9%	$10.4B+8.0%	$10.4B+11.9%	$10.3B+14.8%	$9.9B+25.1%	$9.6B+28.7%	$9.3B+29.1%	$9.0B+33.3%

SNPS Cash Flow Statement

SNPS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$2.9B	$1.5B+7.9%	$1.4B-17.4%	$1.7B-2.0%	$1.7B+16.5%	$1.5B+50.6%	$991.3M+23.8%	$800.5M+88.6%	$424.4M-32.9%	$632.5M+7.8%	$586.6M+18.5%	$495.2M-10.1%	$551.0M+10.9%	$496.7M+2.2%	$486.1M+10.4%	$440.3M
Depreciation & Amortization	N/A	$660.4M+123.8%	$295.1M+19.4%	$247.1M+8.2%	$228.4M+12.1%	$203.7M-3.0%	$210.0M+4.1%	$201.7M-3.6%	$209.2M+10.4%	$189.4M-8.5%	$207.0M-2.3%	$211.8M+9.9%	$192.8M+2.9%	$187.4M+19.5%	$156.8M+22.0%	$128.6M
Stock-Based Compensation	N/A	$893.3M+29.0%	$692.3M+22.9%	$563.3M+22.7%	$459.0M+32.9%	$345.3M+38.9%	$248.6M+60.4%	$155.0M+10.7%	$140.0M+29.3%	$108.3M+11.0%	$97.6M+12.9%	$86.4M+8.8%	$79.4M+17.7%	$67.5M-5.5%	$71.4M+26.6%	$56.4M
Capital Expenditures	$190.6M	$169.5M+21.5%	$139.5M-26.4%	$189.6M+38.8%	$136.6M+45.7%	$93.8M-39.4%	$154.7M-21.9%	$198.1M+100.2%	$99.0M+40.7%	$70.3M+5.1%	$66.9M-23.1%	$87.0M-15.8%	$103.3M+57.8%	$65.5M+20.8%	$54.2M-5.5%	$57.3M
Free Cash Flow	$2.7B	$1.3B+6.4%	$1.3B-16.3%	$1.5B-5.5%	$1.6B+14.5%	$1.4B+67.2%	$836.6M+38.9%	$602.4M+85.1%	$325.4M-42.1%	$562.2M+8.2%	$519.7M+27.3%	$408.2M-8.8%	$447.7M+3.8%	$431.2M-0.1%	$431.9M+12.8%	$383.0M
Investing Cash Flow	$918.2M	-$15.9B-1398.5%	$1.2B+353.7%	-$482.1M+15.8%	-$572.6M-4.3%	-$549.0M-52.3%	-$360.4M-52.8%	-$235.9M+68.3%	-$743.5M-292.8%	-$189.3M	N/A	N/A	-$497.3M-652.5%	-$66.1M+92.5%	-$879.1M-889.8%	-$88.8M
Financing Cash Flow	-$2.7B	$13.4B+7466.8%	-$181.3M+84.9%	-$1.2B-7.2%	-$1.1B-49.1%	-$748.7M-432.5%	-$140.6M+75.0%	-$561.9M-11036.0%	$5.1M+101.4%	-$373.1M	N/A	N/A	-$73.7M+24.8%	-$98.0M-140.2%	$243.5M+187.7%	-$277.6M
Share Buybacks	N/A	$0	$0-100.0%	$1.2B+5.5%	$1.1B+46.1%	$753.1M+211.1%	$242.1M-26.5%	$329.2M-17.7%	$400.0M+5.3%	$380.0M-5.0%	$400.0M+53.8%	$260.0M+117.1%	$119.7M-17.4%	$145.0M+262.5%	$40.0M-90.0%	$401.8M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$812.8M+21.1%	$628.9M+128.4%	$856.8M+1370.2%	$639.7M+13.7%	$671.0M+47.3%	$275.4M-42.2%	-$67.5M+23.2%	$562.8M+72.6%
Depreciation & Amortization	$454.8M+297.4%	$456.5M+833.4%	$450.7M+840.2%	$449.1M+290.8%	$114.5M+103.5%	$48.9M-19.8%	$47.9M-23.8%	$114.9M+71.3%
Stock-Based Compensation	$231.6M-13.5%	$222.3M+10.2%	$258.7M+38.8%	N/A	$267.7M+47.5%	$201.7M+13.4%	$186.5M+3.2%	N/A
Capital Expenditures	$66.6M+72.4%	$54.2M-2.5%	$35.3M-13.3%	$34.5M+66.7%	$38.6M-3.5%	$55.6M+44.9%	$40.7M+0.8%	$20.7M-61.0%
Free Cash Flow	$746.3M+18.0%	$574.7M+161.5%	$821.5M+859.5%	$605.2M+11.6%	$632.4M+52.2%	$219.8M-49.8%	-$108.2M+15.6%	$542.1M+98.6%
Investing Cash Flow	$443.1M+102.7%	-$52.9M-169.6%	-$36.5M-66.1%	$564.4M-60.9%	-$16.5B-30572.5%	$76.0M+168.0%	-$22.0M+59.6%	$1.4B+580.1%
Financing Cash Flow	-$37.8M-100.9%	-$281.0M-102.8%	-$1.6B-1016.2%	-$835.9M-2877.5%	$4.2B+7558.1%	$10.1B+30899.2%	-$141.8M+24.2%	$30.1M+111.8%
Share Buybacks	$37.5M	N/A	N/A	$0	$0	N/A	N/A	$0-100.0%

Not reported in any period shown, so not listed: Dividends Paid.

SNPS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNPS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	77.0%-2.7pp	79.7%-0.9pp	80.6%+7.5pp	73.2%-6.3pp	79.5%+1.1pp	78.4%+0.8pp	77.6%+1.2pp	76.4%+0.4pp	76.0%-1.6pp	77.6%+0.7pp	76.9%-0.9pp	77.8%+0.9pp	76.9%-0.7pp	77.6%-0.2pp	77.8%
Operating Margin	13.0%-9.2pp	22.1%-1.8pp	23.9%+1.3pp	22.6%+5.1pp	17.5%+0.7pp	16.8%+1.4pp	15.5%+3.9pp	11.5%-1.2pp	12.8%-0.3pp	13.1%+1.2pp	11.9%-0.2pp	12.1%-0.5pp	12.6%+1.7pp	10.8%-3.0pp	13.9%
Net Margin	18.9%-18.1pp	36.9%+13.8pp	23.1%+3.8pp	19.4%+1.4pp	18.0%0.0pp	18.0%+2.2pp	15.8%+2.0pp	13.9%+8.8pp	5.0%-6.0pp	11.0%+0.9pp	10.1%-2.5pp	12.6%0.0pp	12.6%+2.3pp	10.4%-4.1pp	14.4%
Return on Equity	4.7%-20.5pp	25.2%+5.2pp	20.0%+2.2pp	17.8%+3.5pp	14.3%+0.8pp	13.5%+0.5pp	13.0%+0.6pp	12.4%+8.3pp	4.2%-4.2pp	8.3%+1.1pp	7.2%-1.3pp	8.5%-0.4pp	8.9%+1.6pp	7.3%-3.3pp	10.5%
Return on Assets	2.8%-14.6pp	17.3%+5.4pp	11.9%+1.4pp	10.4%+1.8pp	8.7%+0.4pp	8.3%0.0pp	8.3%+1.3pp	7.0%+4.5pp	2.5%-2.6pp	5.1%+0.6pp	4.5%-1.0pp	5.4%-0.3pp	5.7%+1.3pp	4.4%-2.2pp	6.6%
Current Ratio	1.62-0.8x	2.44+1.3x	1.15+0.1x	1.09-0.1x	1.160.0x	1.19+0.2x	0.99+0.3x	0.73-0.3x	1.040.0x	1.00+0.1x	0.93-0.2x	1.09-0.1x	1.18+0.3x	0.91-0.4x	1.32
Debt-to-Equity	0.48+0.5x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.020.0x	0.030.0x	0.040.0x	0.040.0x	0.000.0x	0.000.0x	0.010.0x	0.030.0x	0.04-0.6x	0.60
Asset Turnover	0.15-0.3x	0.470.0x	0.510.0x	0.54+0.1x	0.480.0x	0.46-0.1x	0.520.0x	0.510.0x	0.500.0x	0.460.0x	0.440.0x	0.430.0x	0.450.0x	0.420.0x	0.46
FCF Margin	19.1%-1.6pp	20.7%-7.8pp	28.5%-3.1pp	31.5%-1.7pp	33.3%+10.6pp	22.7%+4.8pp	17.9%+7.5pp	10.4%-10.2pp	20.6%-0.8pp	21.4%+3.2pp	18.2%-3.5pp	21.8%-0.2pp	22.0%-2.6pp	24.6%-0.4pp	24.9%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	72.6%-5.6pp	72.3%-7.8pp	73.5%-7.9pp	71.0%-6.1pp	78.1%-2.8pp	80.2%+0.8pp	81.5%-0.1pp	77.1%-5.2pp
Operating Margin	14.4%+4.9pp	5.3%-18.2pp	8.4%-8.9pp	5.4%-13.6pp	9.5%-14.1pp	23.5%+0.6pp	17.3%-6.0pp	19.0%-12.7pp
Net Margin	22.0%+8.1pp	0.8%-20.8pp	2.7%-17.6pp	19.9%-48.2pp	13.9%-12.8pp	21.5%+1.4pp	20.3%-9.4pp	68.1%+42.0pp
Return on Equity	1.8%+0.9pp	0.1%-3.4pp	0.2%-3.0pp	1.6%-10.8pp	0.9%-4.4pp	3.5%-0.6pp	3.2%-3.5pp	12.4%+6.7pp
Return on Assets	1.1%+0.6pp	0.0%-1.4pp	0.1%-2.1pp	0.9%-7.6pp	0.5%-3.0pp	1.5%-1.2pp	2.3%-2.0pp	8.5%+5.1pp
Current Ratio	1.34-0.3x	1.43-5.6x	1.36-1.3x	1.62-0.8x	1.62-0.4x	7.02+5.2x	2.68+1.4x	2.44+1.3x
Debt-to-Equity	0.29-0.2x	0.33-0.7x	0.33+0.3x	0.48+0.5x	0.52+0.5x	1.01+1.0x	0.000.0x	0.000.0x
Asset Turnover	0.050.0x	0.050.0x	0.05-0.1x	0.05-0.1x	0.04-0.1x	0.07-0.1x	0.110.0x	0.130.0x
FCF Margin	30.1%-6.2pp	25.3%+11.5pp	34.1%+41.5pp	26.8%-6.3pp	36.4%+9.1pp	13.7%-16.4pp	-7.4%+1.0pp	33.1%+12.8pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Synopsys Inc SNPS	FY2025	$7.1B	$1.3B	18.9%	$75.5B	57/100
Cloudflare Inc NET	FY2025	$2.2B	-$102.3M	-4.7%	$99.3B	52/100
Fortinet FTNT	FY2025	$6.8B	$1.9B	27.3%	$114.7B	78/100
CrowdStrike Holdings CRWD	FY2026	$4.8B	-$161.2M	-3.4%	$218.2B	63/100
Palo Alto Networks, Inc. PANW	FY2025	$9.2B	$1.1B	12.3%	$271.6B	54/100
Block Inc XYZ	FY2025	$24.2B	$1.3B	5.4%	$49.7B	51/100

Where Synopsys Inc Ranks

Frequently Asked Questions

What is Synopsys Inc's annual revenue?

Synopsys Inc (SNPS) reported $7.1B in total revenue for fiscal year 2025. This represents a 15.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Synopsys Inc's revenue growing?

Synopsys Inc (SNPS) revenue grew by 15.1% year-over-year, from $6.1B to $7.1B in fiscal year 2025.

Is Synopsys Inc profitable?

Yes, Synopsys Inc (SNPS) reported a net income of $1.3B in fiscal year 2025, with a net profit margin of 18.9%.

What is Synopsys Inc's EBITDA?

Synopsys Inc (SNPS) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Synopsys Inc have?

As of fiscal year 2025, Synopsys Inc (SNPS) had $2.9B in cash and equivalents against $13.5B in long-term debt.

What is Synopsys Inc's gross margin?

Synopsys Inc (SNPS) had a gross margin of 77.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Synopsys Inc's operating margin?

Synopsys Inc (SNPS) had an operating margin of 13.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Synopsys Inc's net profit margin?

Synopsys Inc (SNPS) had a net profit margin of 18.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Synopsys Inc's return on equity (ROE)?

Synopsys Inc (SNPS) has a return on equity of 4.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Synopsys Inc's free cash flow?

Synopsys Inc (SNPS) generated $1.3B in free cash flow during fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Synopsys Inc's operating cash flow?

Synopsys Inc (SNPS) generated $1.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Synopsys Inc's total assets?

Synopsys Inc (SNPS) had $48.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Synopsys Inc's capital expenditures?

Synopsys Inc (SNPS) invested $169.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Synopsys Inc spend on research and development?

Synopsys Inc (SNPS) invested $2.5B in research and development during fiscal year 2025.

How many shares does Synopsys Inc have outstanding?

Synopsys Inc (SNPS) had 191M shares outstanding as of fiscal year 2025.

What is Synopsys Inc's current ratio?

Synopsys Inc (SNPS) had a current ratio of 1.62 as of fiscal year 2025, which is generally considered healthy.

What is Synopsys Inc's debt-to-equity ratio?

Synopsys Inc (SNPS) had a debt-to-equity ratio of 0.48 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Synopsys Inc's return on assets (ROA)?

Synopsys Inc (SNPS) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Synopsys Inc's P/E ratio?

Synopsys Inc (SNPS) trades at 70.1x earnings, its market capitalization divided by net income of $1.1B net income, trailing 12 months to July 31, 2026. The market capitalization is $75.5B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Synopsys Inc's price-to-sales ratio?

Synopsys Inc (SNPS) trades at 8.0x sales, its market capitalization divided by revenue of $9.4B revenue, trailing 12 months to July 31, 2026. The market capitalization is $75.5B as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Synopsys Inc's Altman Z-Score?

Synopsys Inc (SNPS) has an Altman Z-Score of 2.84, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Synopsys Inc's Piotroski F-Score?

Synopsys Inc (SNPS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Synopsys Inc's earnings high quality?

Synopsys Inc (SNPS) has an earnings quality ratio of 1.14x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Synopsys Inc cover its interest payments?

Synopsys Inc (SNPS) has an interest coverage ratio of 2.05x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Synopsys Inc?

Synopsys Inc (SNPS) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.